NWU Institutional Repository

In vitro anti-trypanosomal activity of synthetic nitrofurantoin-triazole hybrids against Trypanosoma species causing human African trypanosomosis

dc.contributor.authorSeetsi, Anna en_ZA
dc.contributor.authorRamatla, Tsepoen_ZA
dc.contributor.authorThekisoe, Orielen_ZA
dc.contributor.authorN’da, David D.en_ZA
dc.contributor.authorMolefe-Nyembe, Nthatisien_ZA
dc.contributor.authorSuganuma, Keisukeen_ZA
dc.date.accessioned2025-09-29T07:06:18Zen_ZA
dc.date.issued2023en_ZA
dc.descriptionArticle, Faculty of Natural and Agricultural Sciences (Environmental Sciences and Management)--Northwest University, Potchefstroom Campusen_ZA
dc.description.abstractHuman African trypanosomosis (HAT) which is also known as sleeping sickness is caused by Trypanosoma brucei gambiense that is endemic in western and central Africa and T. b. rhodesiense that is endemic in eastern and southern Africa. Drugs used for treatment against HAT first stage have limited effectiveness, and the second stage drugs have been reported to be toxic, expensive, and have time-consuming administration, and parasitic resistance has developed against these drugs. The aim of this study was to evaluate the anti-trypanosomal activity of nitrofurantoin-triazole hybrids against T. b. gambiense and T. b. rhodesiense parasites in vitro. This study screened 19 synthesized nitrofurantoin-triazole (NFT) hybrids on two strains of human trypanosomes, and cytotoxicity was evaluated on Madin-Darby bovine kidney (MDBK) cells. The findings in this study showed that an increase in the chain length and the number of carbon atoms in some n-alkyl hybrids influenced the increase in anti-trypanosomal activity against T. b. gambiense and T. b. rhodesiense. The short-chain n-alkyl hybrids showed decreased activity compared to the long-chain n-alkyl hybrids, with increased activity against both T. b. gambiense and T. b. rhodesiense. Incorporation of additional electron-donating substituents in some NFT hybrids showed increased anti-trypanosomal activity than to electron- withdrawing substituents in NFT hybrids. All 19 NFT hybrids tested dis- played better anti-trypanosomal activity against T. b. gambiense than T. b. rhodesiense. The NFT hybrid no. 16 was among the best performing hybrids against both T. b. gambiense (0.08 ± 0.04 μM) and T. b.rhodesiense (0.11± 0.06 μM), and its activity might be influenced by the introduction of fluorine in the para-position on the benzyl ring. Remarkably, the NFT hybrids in this study displayed weak to moderate cytotoxicity on MDBK cells. All of the NFT hybrids in this study had selectivity index values ranging from 18 to greater than 915, meaning that they were up to 10-100 times fold selective in their anti-trypanosomal activity. The synthesized NFT hybrids showed strong selectivity >10 to T. b. gambiense and T. b. rhodesiense, which indi- cates that they qualify from the initial selection criteria for potential hit drugs.en_ZA
dc.description.sponsorshipNational Research Foundationen_ZA
dc.identifier.citationSeetsi, Anna. et al. 2023. In vitro anti-trypanosomal activity of synthetic nitrofurantoin-triazole hybrids against Trypanosoma species causing human African trypanosomosis. [https://doi.org/10.1111/fcp.12940]en_ZA
dc.identifier.urihttps://doi.org/10.1111/fcp.12940en_ZA
dc.identifier.urihttp://hdl.handle.net/10394/43443en_ZA
dc.language.isoenen_ZA
dc.publisherWILEYen_ZA
dc.subjectanti-trypanosomal activityen_ZA
dc.subjectnitrofurantoin-triazole hybridsen_ZA
dc.subjectT. b. rhodesienseen_ZA
dc.subjectTrypanosoma brucei gambienseen_ZA
dc.titleIn vitro anti-trypanosomal activity of synthetic nitrofurantoin-triazole hybrids against Trypanosoma species causing human African trypanosomosisen_ZA
dc.typeArticleen_ZA

Files

Original bundle

Now showing 1 - 1 of 1
Loading...
Thumbnail Image
Name:
Thekiso, O. et al. 2023.pdf
Size:
1.32 MB
Format:
Adobe Portable Document Format

License bundle

Now showing 1 - 1 of 1
Loading...
Thumbnail Image
Name:
license.txt
Size:
1.71 KB
Format:
Item-specific license agreed upon to submission
Description:

Collections